Rankings / Sleep & Recovery

Boswellia serrata (AKBA)

Sleep & Recovery · Boswellic acid / 5-LOX inhibitor

Tier B+

anti-inflammatoryotc
7.1 / 10
Tier B+
Ev 6 Bn 5 Sf 9

Bottom line

Read Off Label grades Boswellia serrata (AKBA) as B+ (7.1/10) based on moderate evidence, med benefit magnitude, and a low-risk safety profile.

Distinct mechanism from NSAIDs allows combination.

Typical use: 100-500 mg/day standardized extract (30-65% boswellic acids; AKBA 10-30%) — OTC.

What this is

Distinct mechanism from NSAIDs allows combination. 5-Loxin (high-AKBA) trials most impressive for knee OA. Less GI bleeding risk than NSAIDs. Often combined with curcumin for synergy.

Mechanism

Acetyl-11-keto-β-boswellic acid (AKBA) is the principal active; selective non-redox 5-lipoxygenase inhibitor; reduces leukotriene production; anti-inflammatory with distinct mechanism from NSAIDs

Dose & route

100-500 mg/day standardized extract (30-65% boswellic acids; AKBA 10-30%)

Common questions

Does Boswellia serrata (AKBA) work?
Read Off Label rates the evidence for Boswellia serrata (AKBA) as Moderate and the benefit magnitude as med, producing an overall grade of B+ (7.1/10). Distinct mechanism from NSAIDs allows combination.
Is Boswellia serrata (AKBA) safe?
Boswellia serrata (AKBA) has a low risk profile in published human data. Legal status: OTC. This is not medical advice — see the disclaimer.
What is the typical dose for Boswellia serrata (AKBA)?
100-500 mg/day standardized extract (30-65% boswellic acids; AKBA 10-30%)
How does Boswellia serrata (AKBA) work?
Acetyl-11-keto-β-boswellic acid (AKBA) is the principal active; selective non-redox 5-lipoxygenase inhibitor; reduces leukotriene production; anti-inflammatory with distinct mechanism from NSAIDs

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.